Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.75
Delayed Data
As of Jan 17
 -0.05 / -0.86%
Today’s Change
3.11
Today|||52-Week Range
6.90
+5.50%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close5.80
Today’s open5.75
Day’s range5.60 - 5.90
Volume89,498
Average volume (3 months)84,818
Market cap$147.7M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-18.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book17.94

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...-0.25-2.51%
NVLNNovelion Therapeutic...+0.13+1.45%
CDXCChromadex Corp-0.04-1.34%
LFVNLifeVantage Corp-0.22-2.86%
Data as of 01/17/2017

Financials

Next reporting dateApril 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts


Search for Jobs